Zeiher Bernhardt G

Zeiher Bernhardt G is listed in filings as Director at Entrada Therapeutics, Inc.. This profile follows SEC Form 4 activity through May 21, 2026, including purchase activity. Recent filings connect the profile to Entrada Therapeutics, Inc. (TRDA), Abeona Therapeutics Inc. (ABEO), and Amylyx Pharmaceuticals, Inc. (AMLX). The current snapshot covers public activity from Jun 14, 2024 to May 21, 2026. Reported amounts are shown as $29.3K to $126.3K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.